Linaclotide, typically prescribed for chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C), represents a novel approach to gastrointestinal function. This GC-C agonist works directly within the intestines to increase fluid secretion and expedite bowel movements. Unlike conventional laxatives that primarily act on t